JPM vs Greenhill vs Ducera

Interested in these 3 for their NY offices and want to go to the buy-side after my analyst stint; obviously JPM has top 3 BB prestige (not GS/MS tho) but has group placement risk and a lower return offer rate, Greenhill isn't what it once was but still has solid MM/UMM/MF PE exits, and Ducera pays its analysts $200k+ but has the worst hours and exits generally limited to credit roles. Thoughts?

55 Comments
 
[Comment removed by mod team]
 

not OP, but at least in the CHI office all greenhill analysts exit to MF/UMM, exits are still top

 

I think you idea that of Ducera exits being limited is partially due to selection bais. In order to have a shot with them you really need to be passionate about RX and I think that just leads to more moving to credit buyside. I know they had a couple people that exited to HIG and 1 to EQT in the last couple years, which isn't bad given class size. Anyways, if you just want to do M&A, I would say JPM > Greenhill >= Ducera(mix M&A and RX) not sure how much longer Greenhill over Ducera will last, since one is struggle and one is growing.

 

Are these things still true? You can't even find Greenhill on league tables anymore while they used to be top 15 ten years ago.

Yes to pay and placements. League tables is not totally indicative of buyside interest. There is a lot of prestige/legacy/preference factor. There was another thread awhile ago that compiled buyside placement from BB's. Credit Suisse was the strongest out of mid-tier BB's even though their deal volume has fallen behind over the past few years.

 
Most Helpful

If you let WSO convince you to take Greenhill over JPM, you shouldn't have a JPM offer. Can't think of a single buy-side firm that hires from Greenhill and not JPM or in preference to them, whereas in any exit outside finance, JPM >>>>> Greenhill.

 

Agreed but it’s not just about that. It’s more about the people and whom did they connect with in chats interviews etc.., especially if exits are not so important. Given most people exit I do agree…. But id pick ducera personally since I’m really interested in rx… just about preferences yknow

 

JPM definitely has the same prestige factor and a much, much stronger brand globally, but for the purpose of OP's question we cannot ignore group placement risk. If M&A deal flow does indeed "die", how will the MD's react? And how will that affect the analyst experience? It's a hypothetical question that nobody really knows.  It is a good thought to ponder on though.

 

For prestige exit opps take JPM, the worst that can happen is you end up at ECM or DCM every coverage group at JPM is pretty strong, especially their healthcare team, have seen MF/UMM exits across all groups

 

If you’re interested in buyout roles or M&A type stuff then JPM hands down. If you know you’re interested in distressed or special situations then Ducera would be best.

 

GHL still has historically placed a good proportion of their classes into buyside. However, a lot of one's buyside recruiting success comes from the individual and their experiences rather than the bank brand - that only gets the foot in the door.

 

Asperiores esse omnis laboriosam ut qui. Est commodi eveniet et ad. Asperiores rerum neque qui eligendi sit animi. Enim quod temporibus eligendi. Pariatur enim numquam sequi.

 

Assumenda qui quibusdam voluptatem voluptatem ipsum nisi ullam non. Unde odio ad fugiat repellendus dolores. Ipsa corrupti consectetur est et in. Voluptatibus quam numquam veritatis distinctio iste voluptatum officia et. Fuga qui maxime et amet.

Beatae soluta et enim nesciunt sunt. Asperiores et maxime cupiditate non. Cumque accusantium autem ut incidunt enim ut.

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Morgan Stanley 08 97.8%
  • Goldman Sachs 02 97.2%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.3%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.2%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.8%
  • JPMorgan 01 97.2%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (47) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (25) $178
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (83) $151
  • Intern/Summer Analyst (74) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
dosk17's picture
dosk17
98.9
6
CompBanker's picture
CompBanker
98.9
7
GameTheory's picture
GameTheory
98.9
8
DrApeman's picture
DrApeman
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”